NMR Probe is suited for protein applications.
Press Release Summary:
Designed to determine molecular structures of proteins and other biomolecules in solid state, BioStatic(TM) NMR probe allows access to 70% of all cellular proteins including membrane proteins. It incorporates ultra-low E-field coil technology to reduce unwanted heating by up to 94%. Probe provides researchers with insight into proteins and biomarker molecules associated with wide variety of diseases.
Original Press Release:
Varian, Inc. Debuts BioStatic(TM) NMR Probe for Protein Applications
PALO ALTO, Calif., April 24 / / -- Varian, Inc. (NASDAQ:VARI) has extended its offerings for bio-solids applications research by introducing the BioStatic(TM) nuclear magnetic resonance (NMR) probe designed to determine the molecular structures of proteins and other biomolecules in a solid state.
Bio-solids NMR experiments allow access to 70% of all cellular proteins, such as membrane proteins, that are considered solids because they are not free floating in intracellular fluid. These analyses can provide researchers with unparalleled insight into proteins and biomarker molecules associated with a wide variety of diseases.
Varian's BioStatic probe incorporates patent pending ultra-low E-field coil technology to reduce unwanted heating by up to 94% compared to a standard solenoid coil design probe, and enables experiments to be run up to 5x faster than competitive offerings. Low transfer of heat to the sample is important to researchers because heating can alter or destroy valuable biological solids samples.
"Membrane proteins are of considerable interest to our customers because they represent approximately 65 percent of current drug targets," said Martin O'Donoghue, senior vice president of Scientific Instruments, Varian, Inc. "The BioStatic probe is another product in our information rich detection (IRD) portfolio that demonstrates the continuing innovation of our NMR research and development team."
Orders are being accepted now for the new BioStatic probe with delivery scheduled to begin later this calendar year.
Core to Varian, Inc.'s strategy is strengthening the company's IRD product portfolio, which provides users with multi-dimensional layers of knowledge critical to their ability to optimize analyses and processes. These products include nuclear magnetic resonance (NMR) and magnetic resonance (MR) imaging, mass spectrometry (MS) and Fourier Transform-infrared (FT-IR) systems. For additional information about the BioStatic(TM) probe, please visit www.varianinc.com/products/nmr/probes/solids/index.html
Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum components, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,700 people and operates manufacturing facilities in 14 locations in North America, Europe, and the Pacific Rim. Varian, Inc. had fiscal year 2005 sales of $773 million (excluding the divested Electronics Manufacturing business), and its common stock is traded on Nasdaq under the symbol, "VARI." Further information is available on the company's Web site: www.varianinc.com.
Source: Varian, Inc.
CONTACT:
David Jorissen of Varian, Inc.,
+1-650-424-5327, or
david.jorissen@varianinc.com
Web site: www.varianinc.com/
